Classer les publications sur l'année
-
Pharmaco-Epidémiologie
Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient : a prospective, randomised study
DAHAN E, BEN SIMON GJ, LAFUMA A
Eye ; 2012;26(5):703-710
-
Pharmaco-Epidémiologie
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes
DETOURNAY B, SIMON D, GUILLAUSSEAU PJ, JOLY D, VERGES B, ATTALI C, CLEMENT O, BRIAND Y, DELAITRE O
Diabetes Metab ; 2012;38:102-112
-
Pharmaco-Epidémiologie
An observational study of the initial management of hypothyroidism in France : the ORCHIDEE Study
DELEMER B, AUBERT JP, NYS P, LANDRON F, BOUEE S
Eur J Endocrinol ; 2012;167:817-823
-
Pharmaco-Epidémiologie
A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: The AVANCE study
HALIMI S, AUBERT JP, FONTBONNE A, GUILLAUSSEAU PJ, NACHIT F, BOUEE S, DETOURNAY B
Diabetes Metab ; 2012;38:343-351
-
Pharmaco-Epidémiologie
Traitements antidiabĂ©tiques des patients diabĂ©tiques de type 2 atteints dâune insuffisance rĂ©nale modĂ©rĂ©e ou sĂ©vĂšre suivis en mĂ©decine gĂ©nĂ©rale en France
BOUEE S, GAUDIN AF, AMELINEAU E, BONNET F
Thérapie ; 2013;68(1):19-26
-
Ăconomie de la santĂ©
The association between asthma control, health care costs, and quality of life in France and Spain
DOZ M, CHOUAID C, COM-RUELLE L, CALVO E, BROSA M, ROBERT J, DECUYPERE L, PRIBIL C, HUERTA A, DETOURNAY B
BMC Pulm Med ; 2013;22:13-15
-
Ăconomie de la santĂ©
Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study
VILLANUEVA V, GIRĂN JM, MARTĂN J, HERNĂNDEZ-PASTOR LJ, LAHUERTA J, DOZ M, CUESTA M, LĂVY-BACHELOT L; INVESTIGADORES DEL ESTUDIO ESPERA
Neurologia ; 2013;28(4):195-204
-
Ăconomie de la santĂ©
Le reste à charge des patients diabétiques en France en 2007
DETOURNAY B, ROBERT J, GADENNE S
BEH ; 2013;37-38:471-476
-
Ăconomie de la santĂ©
LâĂ©valuation mĂ©dico-Ă©conomique des produits de santĂ© dans le contexte de la loi de financement de la SĂ©curitĂ© sociale pour 2012
DERVAUX B, BASEILHAC E, FAGON JY, AMEYE V, ANGOT P, AUDRY A, BECQUEMONT L, BOREL T,CAZENEUVE B, COURTOIS J, DETOURNAY B, FAVRE P, et al
Thérapie ; 2013;68(4):253-257
-
Ăconomie de la santĂ©
IntĂ©rĂȘt des bases de remboursement de lâAssurance maladie pour lâanalyse de la prise en charge des maladies chroniques : le cas de lâĂ©pilepsie
FAGNANI F, VESPIGNANI H, KUSNIK-JOINVILLE O, BERTRAND M, MURAT C, LEVY-BACHELOT L, KAHANE P
Presse Med ; 2013;42:285-292
-
Ăconomie de la santĂ©
Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses
YE X, LAFUMA A, TORRETON E, ARNAUD A
BMC Health Serv Res ; 2013;13(1):186
-
Pharmaco-Epidémiologie
Hereditary angioedema with C1 inhibitor deficiency : clinical presentation and quality of life of 193 French patients
BOUILLET L, DAVID LAUNAY D, FAIN O, BOCCON-GIBOD I, LAURENT J, MARTIN L, MONTAUBAN V, FINCK K, BOUĂE S, GOMPEL A, KANNY G
Ann Allergy Asthma Immunol ; 2013;111:290-294
-
Pharmaco-Epidémiologie
Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross Sectional Study
GRANDFILS N, DETOURNAY B, ATTALI C, JOLY D, SIMON D, VERGES B, TOUSSI M, BRIAND Y, DELAITRE O
Int J Endocrinol ; 2013;2013:640632
-
Pharmaco-Epidémiologie
Facteurs associĂ©s Ă lâhospitalisation des personnes diabĂ©tiques adultes en France Entred 2007
ASSOGBA F , PENFORNIS F , DETOURNAY B, LECOMTEÂ P, BOURDEL-MARCHASSON I, DRUET C , WEILL A , FAGOT-CAMPAGNA A, FOSSE-EDORH S
BEH ; 2013;37-38:454-463
-
Pharmaco-Epidémiologie
Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof(Âź) SN60WF, Akreos(Âź) AO-MI60 and Hoya(Âź) YA-60BB
BOURDIOL DUCASSE AM, GUERZIDER V, VELASQUE L, DOMINGUEZ M, LAFUMA A, ROBERT J
J Fr Ophtalmol ; 2013;36:575-582
  Â